Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets
Wednesday, July 22, 2020Clarity Pharmaceuticals a radiopharmaceutical company focused on the treatment of serious disease and ImaginAb Inc a company that harnesses the specificity of monoclonal antibodies have entered into a collaboration agreement to develop new targeted t...
Jnana Therapeutics Enters Collaboration with Roche to Discover Novel Medicines that Target Key Regulators of Cellular Metabolism to Treat Immune-Mediated and Neurological Diseases
Wednesday, July 22, 2020Jnana Therapeutics announced a strategic multitarget collaboration and license agreement with Roche for the discovery of small molecule drugs directed at the solute carrier SLC family of metabolite transporters as a broad innovative approach for mod...
JW Therapeutics Acquires Syracuse Biopharma and License to Eureka Therapeutics’ Solid Tumor Technology in China
Tuesday, July 21, 2020JW Therapeutics a clinical stage biopharmaceutical company focused on developing manufacturing and commercializing cell therapies for patients in China announced the acquisition of Syracuse Biopharma Hong Kong Limited which includes the license for E...
Mateon and Asili Research Alliance Enter Into Partnership for the Development of Artemisinin Against Covid-19
Tuesday, July 21, 2020Mateon Therapeutics a leading developer of TGF therapeutics announced the launch of its global observational study called ARTI for Artemisinin Intervention against COVID in partnership with Asili Research Alliance Asili of Tanzania ARTI is designed t...
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
Monday, July 20, 2020Pfizer Inc and BioNTech SE announced an agreement with the United Kingdom to supply million doses of their BNT mRNAbased vaccine candidate against SARSCoV currently in development subject to clinical success and regulatory approval Financial details...
GSK and CureVac announce strategic mRNA technology collaboration
Monday, July 20, 2020GlaxoSmithKline plc and CureVac today announced the signing of a strategic collaboration agreement for the research development manufacturing and commercialisation of up to five mRNAbased vaccines and monoclonal antibodies mAbs targeting infectious d...
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China
Saturday, July 18, 2020BeiGene Ltd a commercialstage biotechnology company focused on developing and commercializing innovative molecularlytargeted and immunooncology drugs for the treatment of cancer announced that the Center for Drug Evaluation CDE of the China National...
Celltrion Launches Human Clinical Trial of Potential COVID-19 Antiviral Antibody Treatment Following Positive Pre-Clinical Results
Saturday, July 18, 2020Celltrion Group announced the launch of its Phase I human clinical trial investigating a potential antiviral antibody treatment for patients with COVID The inhuman study follows positive preclinical results for the treatment candidate and subsequent...
Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab
Friday, July 17, 2020Catalent and Humanigen Incannounced the expansion of their relationship under which Catalent will provide development manufacturing and commercialization services for lenzilumab Humanigens proprietary Humaneered antihuman granulocyte macrophagecolony...
Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus’ ONCR-177 with Merck’s KEYTRUDA®
Friday, July 17, 2020Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus ONCR with Mercks KEYTRUDA pembrolizumab in Adult Patients with Advanced andor Refractory Cutaneous Subcutaneous or Metastatic Nodal Solid Tumors
